Business Standard

Sunday, December 22, 2024 | 09:57 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Centre allows Bharat Biotech to begin commercial exports of Covaxin

Bharat Biotech made 55 million doses of Covaxin in October, and aims to make 80 million doses in December.

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Sohini Das Mumbai
Paving the way for commercial exports of Covid-19 vaccines to start from India, the Centre allowed Hyderabad-based vaccine maker Bharat Biotech to start commercial exports of Covaxin on Tuesday, according to sources in the know. 

A few days back, its peer Pune’s Serum Institute of India (SII), was allowed to export to the WHO-led vaccine initiative COVAX.

Bharat Biotech did not wish to comment on the matter. SII, too, did not confirm if it got a nod to start commercial bilateral exports from the Indian government.

Bharat Biotech made 55 million doses of Covaxin in October, and aims to make 80 million doses

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in